LEE; Chun Geun

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEE; Chun Geun.The latest application filed is for "bispecific antibodies against chi3l1 and pd1 with enhanced t cell-mediated cytotoxic effects on tumor cells".

Company Profile

10.7.16

LEE; Chun Geun - Providence CT
LEE; Chun Geun - Woodbridge CT
Lee; Chun Geun - New Haven CT US
Lee; Chun Geun - Orange CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bispecific Antibodies Against Chi3l1 And Pd1 With Enhanced T Cell-mediated Cytotoxic Effects On Tumor Cells App 20220213193 - ELIAS; Jack A. ; et al.	2022-07-07
Methods And Compositions Relating To The Treatment Of Fibrosis App 20220117987 - ELIAS; Jack A. ; et al.	2022-04-21
Methods and compositions relating to the treatment of fibrosis Grant 11,219,630 - Elias , et al. January 11, 2	2022-01-11
Methods And Compositions Relating To Anti-chi3l1 Antibody Reagents For The Treatment Of Fibrosis App 20210395377 - ELIAS; Jack A. ; et al.	2021-12-23
Methods And Compositions Relating To The Treatment Of Fibrosis App 20210128595 - ELIAS; Jack A. ; et al.	2021-05-06
Methods And Compositions Relating To Anti-chi3l1 Antibody Reagents App 20210009712 - ELIAS; Jack A. ; et al.	2021-01-14
Methods And Compositions Relating To Anti-chi3l1 Antibody Reagents App 20200354474 - ELIAS; Jack A. ; et al.	2020-11-12
Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer Grant 10,766,968 - Elias , et al. Sep	2020-09-08
Methods and compositions relating to anti-CHI3L1 antibody reagents to treat nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NFALD) or metabolic syndrome Grant 10,752,700 - Elias , et al. A	2020-08-25
Methods And Compositions Relating To Anti-chi3l1 Antibody Reagents App 20190119405 - Elias; Jack A. ; et al.	2019-04-25
Methods and compositions relating to anti-Chi3l1 antibody reagents Grant 10,253,111 - Elias , et al.	2019-04-09
Methods And Compositions Relating To Anti-chi3l1 Antibody Reagents App 20190062457 - Elias; Jack A. ; et al.	2019-02-28
Methods For Decreasing Chord Length App 20190030119 - Elias; Jack A. ; et al.	2019-01-31
Methods And Compositions Relating To Anti-chi3l1 Antibody Reagents App 20190002586 - ELIAS; Jack A. ; et al.	2019-01-03
Methods for the diagnosis and treatment of pulmonary fibrosis in subjects with hermansky pudlak syndrome Grant 9,994,905 - Elias , et al. June 12, 2	2018-06-12
Methods For The Diagnosis And Treatment Of Pulmonary Fibrosis In Subjects With Hermansky Pudlak Syndrome App 20170121773 - ELIAS; Jack A. ; et al.	2017-05-04
Methods For Treating Lung Disease App 20160263183 - Elias; Jack A. ; et al.	2016-09-15
Methods And Compositions Relating To The Treatment Of Visceral Fat And Asthma App 20160166520 - ELIAS; Jack A. ; et al.	2016-06-16
Chi3l1 For The Detection And Treatment Of Nonalcoholic Steatohepatitis App 20160139149 - ELIAS; Jack A. ; et al.	2016-05-19
Semaphorin 7A plays a critical role in TGF-.beta..sub.1-induced pulmonary fibrosis and alveolar destruction Grant 8,642,357 - Elias , et al. February 4, 2	2014-02-04
IL-18 and Protein Kinase R Inhibition for the Treatment of COPD App 20100247538 - Elias; Jack A. ; et al.	2010-09-30
Semaphorin 7A Plays a Critical Role in TGF-Beta1-Induced Pulmonary Fibrosis and Alveolar Destruction App 20100104570 - Elias; Jack A. ; et al.	2010-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.